Prediction of outcome in patients with colorectal cancer (CRC) is challenging as a result of
lack of a robust biomarker and heterogeneity between and within tumors. The aim of this …

The high incidence of rectal cancer in both sexes makes it one of the most common tumors,
with significant morbidity and mortality rates. To define the best treatment option and …

Colorectal cancer (CRC) is the third leading cause of cancer death globally. Early detection
and removal of precancerous polyps can significantly reduce the chance of CRC patient …

Locally advanced rectal cancer (LARC) response to neoadjuvant chemoradiotherapy
(nCRT) is very heterogeneous and up to 30% of patients are considered non-responders …

BACKGROUND Neoadjuvant chemotherapy is currently recommended as preoperative
treatment for locally advanced rectal cancer (LARC); however, evaluation of treatment …

Objective. The purpose of this study was to investigate the feasibility of applying handcrafted
radiomics (HCR) and deep learning‐based radiomics (DLR) for the accurate preoperative …

Background Accurate pre-treatment prediction of neoadjuvant chemotherapy (NACT)
resistance in patients with locally advanced gastric cancer (LAGC) is essential for timely …

Purpose To investigate the value of multiparametric MRI-based radiomics on predicting
response to nCRT in patients with rectal cancer. Methods This study enrolled 193 patients …

Objectives To develop and validate magnetic resonance imaging (MRI)-based pre-
Radiomics and delta-Radiomics models for predicting the treatment response of local …

Rectal cancer (RC) is the third most commonly diagnosed cancer and has a high risk of
mortality, although overall survival rates have improved. Preoperative assessments and …